Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
848 participants
OBSERVATIONAL
2011-11-30
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidemiology of Thromboembolism Disease: A Cohort Study
NCT00670540
Cohort for Monitoring Patients With Venous Thromboembolic Disease
NCT07016542
DVT Burden and the Risk of Post-thrombotic Syndrome
NCT06385353
Incidence of Venous Thromboembolism and Professional Practices in Brest Area
NCT02895971
Incidence and Risk Factors of Venous Thrombosis of the Lower Limbs After Hospitalization in Medical Patients at Risk
NCT05512923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with suspected SVT
patients with suspected SVT and inhabitants of the Saint Etienne region
consultation with a vascular physician
As in usual practice, patient with suspected SVT will consult a vascular physician to diagnose SVT and eventually DVP/PE associated. Vascular physician will collect risk factors of SVT.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
consultation with a vascular physician
As in usual practice, patient with suspected SVT will consult a vascular physician to diagnose SVT and eventually DVP/PE associated. Vascular physician will collect risk factors of SVT.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with suspected SVT
* consulting general practitioners and or vascular physicians of the Saint Etienne region
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, France
OTHER_GOV
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hervé DECOUSUS, MD PhD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Paul FRAPPE, MD
Role: STUDY_DIRECTOR
University of Saint-Etienne
Bernard TARDY, MD PhD
Role: STUDY_DIRECTOR
CHU de Saint Etienne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cabinet D'Angiologie
Firminy, , France
Ch Firminy
Firminy, , France
Cabinet D'Angiologie
Saint-Chamond, , France
Centre médical de Chavannes
Saint-Chamond, , France
Cabinet D'Angiologie
Saint-Etienne, , France
Chu Saint-Etienne
Saint-Etienne, , France
Clinique Mutualiste CHirurgicale de St-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11.385
Identifier Type: OTHER
Identifier Source: secondary_id
1108036
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.